Thomas A. Raffin Insider Trading $NLNK LUMOS PHARMA, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Thomas A. Raffin.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Thomas A. Raffin. Thomas A. Raffin is Director in NEWLINK GENETICS CORP ($NLNK) and Director in Akoya Biosciences, Inc. ($AKYA).
Thomas A. Raffin in LUMOS PHARMA, INC.
Trading Symbol: NLNKIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Thomas A. Raffin: Director
Holdings: 7,889 shares
Current Value: $107,843
Latest Transaction: Apr 07 2020
$NLNK Market Capitalization: $408.17M
$NLNK Previous Close: $13.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Thomas A. Raffin in LUMOS PHARMA, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 07 2020 | NLNK | LUMOS PHARMA, INC. | Raffin Thomas A. | Director | Option Exercise | A | 7.78 | 5,684 | 44,222 | 5,684 | |
Apr 07 2020 | NLNK | LUMOS PHARMA, INC. | Raffin Thomas A. | Director | Grant | A | 0.00 | 709 | 0 | 7,889 | 7.2 K to 7.9 K (+9.87 %) |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 13,889 | 24,584 | 13,889 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 5.33 | 27,777 | 148,051 | 0 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 4,437 | 7,853 | 4,437 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 17.42 | 13,309 | 231,843 | 0 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 2,391 | 4,232 | 2,391 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 10.78 | 4,782 | 51,550 | 0 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 8,887 | 15,730 | 8,887 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 10.78 | 17,774 | 191,604 | 0 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 1,588 | 2,811 | 1,588 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 44.60 | 6,349 | 283,165 | 0 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 5,220 | 9,239 | 5,220 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 21.23 | 15,659 | 332,441 | 0 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 4,000 | 7,080 | 4,000 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 14.71 | 12,000 | 176,520 | 0 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 5,952 | 10,535 | 5,952 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 13.30 | 17,855 | 237,472 | 0 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 23,810 | 42,144 | 23,810 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 7.00 | 47,619 | 333,333 | 0 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 1,786 | 3,161 | 1,786 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 7.00 | 3,571 | 24,997 | 0 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 8,929 | 15,804 | 8,929 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 10.02 | 17,857 | 178,927 | 0 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 13,095 | 23,178 | 13,095 | |
Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 3.07 | 26,190 | 80,403 | 0 | |
May 14 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.69 | 25,000 | 42,250 | 25,000 | |
May 25 2018 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 5.33 | 27,777 | 148,051 | 27,777 | |
May 16 2017 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 17.42 | 13,309 | 231,843 | 13,309 | |
Aug 11 2016 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 10.78 | 4,782 | 51,550 | 4,782 | |
Aug 11 2016 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 10.78 | 17,774 | 191,604 | 17,774 | |
May 04 2015 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 44.60 | 3,643 | 162,478 | 3,643 | |
May 04 2015 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Grant | A | 0.00 | 1,962 | 0 | 64,621 | 62.7 K to 64.6 K (+3.13 %) |
Apr 09 2015 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | M | 1.96 | 3,205 | 6,282 | 0 | |
Apr 09 2015 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | M | 1.96 | 3,205 | 6,282 | 0 | |
Apr 09 2015 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | M | 10.02 | 7,142 | 71,563 | 0 | |
Apr 09 2015 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | M | 2.10 | 7,142 | 14,998 | 0 | |
Apr 09 2015 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Sell | S | 55.03 | 9,870 | 543,146 | 62,659 | 72.5 K to 62.7 K (-13.61 %) |
Apr 09 2015 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Sell | S | 54.32 | 10,024 | 544,504 | 72,529 | 82.6 K to 72.5 K (-12.14 %) |
Apr 09 2015 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Sell | S | 53.18 | 800 | 42,544 | 82,553 | 83.4 K to 82.6 K (-0.96 %) |
Apr 09 2015 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Buy | M | 1.96 | 3,205 | 6,282 | 83,353 | 80.1 K to 83.4 K (+4.00 %) |
Apr 09 2015 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Buy | M | 1.96 | 3,205 | 6,282 | 80,148 | 76.9 K to 80.1 K (+4.17 %) |
Apr 09 2015 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Buy | M | 10.02 | 7,142 | 71,563 | 76,943 | 69.8 K to 76.9 K (+10.23 %) |
Apr 09 2015 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Buy | M | 2.10 | 7,142 | 14,998 | 69,801 | 62.7 K to 69.8 K (+11.40 %) |
Page: 1